Skip to main content
logo
NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ: NRXP · Real-Time Price · USD
3.400
-0.070 (-2.02%)
Sep 9, 2026, 11:48 AM EDT - Market open

NRx Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
14780273875281
Market Cap Growth
171.39%202.37%-30.71%-48.99%-73.29%328.57%
Enterprise Value
12183313957243
Last Close Price
3.472.712.204.6011.1047.80

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-39.16----
PS Ratio
44.2365.49----
PB Ratio
--5.03-1.14-3.2610.1313.51
P/TBV Ratio
----10.1313.51

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
36.6168.00----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-4.91-0.04-0.27-0.781.420.03
Net Debt / Equity Ratio
152.070.45-0.21-0.39-1.29-1.30
Net Debt / EBITDA Ratio
1.310.45-0.24-0.170.220.29
Net Debt / FCF Ratio
1.250.51-0.45-0.210.240.72
Asset Turnover
0.170.15----
Quick Ratio
0.790.280.070.241.292.32
Current Ratio
0.860.310.150.361.662.74
Return on Equity (ROE)
-----281.79%-
Return on Assets (ROA)
-63.99%-121.85%-224.60%-104.08%-94.66%-330.91%
Return on Capital Employed (ROCE)
-6980.40%103.60%108.20%235.10%-433.30%-453.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-15.64%-35.68%-94.69%-78.73%-52.95%-33.11%
FCF Yield
-13.77%-17.59%-40.09%-56.56%-52.96%-13.41%
Buyback Yield / Dilution
-110.42%-101.06%-40.50%-15.20%-40.17%-36.90%
SEC Filings: 10-K · 10-Q